Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Swiss giant Novartis...

    Swiss giant Novartis likely bribed thousands in Greece

    Written by supriya kashyap kashyap Published On 2017-04-09T10:06:55+05:30  |  Updated On 9 April 2017 10:06 AM IST

    Athens : Greece’s justice minister said Swiss pharmaceutical giant Novartis had likely bribed “thousands” of doctors and civil servants to promote its products, amid an ongoing probe.


    “A great number of state officials are implicated from what I’m beginning to realise from reports, it must be thousands who were directly bribed from Switzerland,” Stavros Kontonis told state agency ANA radio.


    “National health service doctors and state officials were bribed to promote drugs in an illegal and anti-scientific manner,” Kontonis said.


    Scores of people have been questioned in a probe ongoing since last year, with anti-corruption prosecutors also visiting Novartis’s premises near Athens earlier this year to gather evidence.


    The case gained attention following a suicide attempt in Athens on New Year’s Day, by a Novartis manager.


    That attempt was thwarted by police and according to the judicial source, the manager was one of those questioned over alleged corruption.


    Kontonis said Novartis continued to sell “overpriced” drugs even after the country was hit by economic crisis in 2010 and huge cuts were imposed on state budgets, leaving many Greeks without access to affordable medicine.


    In January, Novartis issued a statement saying it was “aware of the media reports about our business practises” in Greece and that it was seeking more information and was cooperating with the authorities.


    “Novartis is committed to the highest standards of ethical business conduct and regulatory compliance in all aspects of its work and takes any allegation of misconduct extremely seriously,” the company said in the statement.


    The Swiss pharmaceutical giant was investigated by US authorities in 2014, accused of paying bribes in order to boost sales of some of its medicines, and was later fined USD 390 million (366 million euros) by the US Justice Department.


    In March, Novartis also paid USD 25 million (22.4 million euros) to settle claims involving its Chinese subsidiary.

    bribedNovartisStavros KontonisSwiss
    Source : AFP

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok